SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

MCKELVEY DANIEL P

(Last)

(First)

(Middle)

100 SHOOTING STAR

(Street)

FOSTER CITY

94904

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/26/2004

3. Issuer Name and Ticker or Trading Symbol
IQ BIOMETRIX INC [ IQBM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	150,000	I⁽¹⁾	By self as Trustee for IRA
Common Stock	1,687,341	I⁽²⁾	Partnership⁽²⁾
Common Stock	30,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrant to purchase Common Stock	04/01/2003	04/01/2008	Warrant	1,200,000⁽³⁾	$0.2	I	Partnership
Convertible Debenture convertible Common Stock	03/31/2004	03/31/2009	Convertible Debenture	1,650,000⁽³⁾	$0.2	I	Partnership
Warrant to Purchase Common Stock	05/01/2003	04/30/2008	Warrant	160,000⁽³⁾	$0.5	I	Partnership

Explanation of Responses:

1. Shares are held indirectly by Mr. McKelvey through his IRA

2. These shares are held by Special Equity IV, L.P. These shares are indirectly held by Daniel P. McKelvey, who is a managing member of Forte Capital Partners, LLC, which is the general partner of Special Equity IV, L.P. Mr. McKelvey disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

3. These shares are indirectly held by Daniel P. McKelvey, who is a managing member of Forte Capital Partners, LLC. Mr. McKelvey disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

	/s/ Daniel P. McKelvey	04/05/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.